Alector (ALEC) News
NASDAQ: ALECHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.08+0.06 (+2.97%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
ALEC news summary
We found 2 recent headlines mentioning Alector (ALEC): 1 in the past week and 2 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, ALEC is up 2.97% at $2.08. The most recent story, "Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled Pipeline", was published by GlobeNewswire on Oct 7, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Alector headlines
- Alector to Host Virtual Research and Development Event Highlighting Wholly Owned Alector Brain Carrier (ABC)- Enabled PipelineAgenda to feature progress for AL137, its lead anti-amyloid beta antibody; AL164, its tau siRNA program; and AL062, its alpha-synuclein siRNA programGlobeNewswire
- Novartis Halts Development Of VHB937 After ASTRALS Phase 2 Trial Fails To Meet Endpoint(RTTNews) - Novartis (NVS) announced on August 25, 2026, that its ASTRALS Phase 2 clinical trial evaluating VHB937 for amyotrophic lateral sclerosis did not meet its primary or secondary endpoints,…NasdaqALEC, NVS